Your browser doesn't support javascript.
loading
CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFß-induced HSC-T6 cells activation.
Ullah, Aftab; Wang, Kaikai; Wu, Pengkai; Oupicky, David; Sun, Minjie.
Afiliação
  • Ullah A; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Wang K; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Wu P; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Oupicky D; State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People's Republic of China.
  • Sun M; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Int J Nanomedicine ; 14: 2927-2944, 2019.
Article em En | MEDLINE | ID: mdl-31118614
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Sistemas de Liberação de Medicamentos / Receptores CXCR4 / Células Estreladas do Fígado / Compostos Heterocíclicos / Cirrose Hepática Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Sistemas de Liberação de Medicamentos / Receptores CXCR4 / Células Estreladas do Fígado / Compostos Heterocíclicos / Cirrose Hepática Idioma: En Ano de publicação: 2019 Tipo de documento: Article